Achiko Logo cropped.jpg
Achiko Establishes Joint Venture with PT Indonesia Farma Medis for Production and Distribution of its Test Platform for Covid-19 in Indonesia
February 12, 2021 07:30 ET | Achiko AG
Achiko Signs Agreement with PT Indonesia Farma Medis to Establish a New Joint Venture, including a Contract with PT Mitra Asa Pratama and a Memorandum of Understanding with PT Pharos Indonesia,...
Achiko Logo cropped.jpg
Achiko Concludes Phase 1 Study of Project Gumnuts for Covid-19 Testing
January 25, 2021 07:30 ET | Achiko AG
Completion of Phase 1 Testing Demonstrates 91% Sensitivity and 85% SpecificityFurther Optimization Studies are Currently Being Performed and are Expected to Continue to Improve Results and Match WHO...
Achiko Logo cropped.jpg
Achiko Strengthens Leadership Team with New President and New SVP Commercialization
January 11, 2021 07:30 ET | Achiko AG
Appoints New President, Biotechnology Research Scientist and Entrepreneur Dr. Morris S. Berrie Appoints New SVP Commercialization, Business Leader in Life Science Richard Lingard New Senior Leadership...
Achiko Logo cropped.jpg
Achiko Partners with Udayana University for Covid-19 Testing Research in Bali, Indonesia
December 04, 2020 07:00 ET | Achiko AG
Achiko signed a research agreement with Udayana University’s Research Department to study the practicability of a mass testing approach with Teman Sehat and Gumnuts when availableThe Study will focus...
Achiko Logo cropped.jpg
Achiko AG Enters into a Convertible Note of Up to CHF $2 Million with Negma Group
November 30, 2020 08:30 ET | Achiko AG
ZURICH, Switzerland, Nov. 30, 2020 (GLOBE NEWSWIRE) -- Achiko AG (SWX:ACHI, ISIN CH0522213468) (“the Company”) has entered into a new subordinated convertible loan transaction of up to CHF $2...
Achiko Logo cropped.jpg
Achiko Secures Convertible Loan Facility with Yorkville Advisors of USD $2.5 Million, with a Provisional Extension of Up to USD $9.5 Million
November 26, 2020 07:00 ET | Achiko AG
ZURICH, Switzerland, Nov. 26, 2020 (GLOBE NEWSWIRE) -- Achiko AG (SWX:ACHI, ISIN CH0522213468) announces the completion of a convertible loan facility with US based fund manager Yorkville Advisors...
Achiko Logo cropped.jpg
Achiko AG Appoints Toolbox Medical Innovations and NDA Group and Expands Advisory Board
November 02, 2020 08:52 ET | Achiko AG
Encouraging Initial Results to Date in Field Validation TrialsToolbox Medical Innovations Engaged for the Design of the Commercial Test KitNDA Group Engaged to Assist in Progress Towards CE...
Achiko Logo cropped.jpg
Achiko Establishes MedTech Expert Advisory Board and Expands Management Team
October 13, 2020 12:09 ET | Achiko AG
New international advisory board members: Mr. Glenn Cross (Australia), Dr. Jittaporn Wattanaseree (Thailand) and Ms. Carol Aebi (Switzerland)Management team appointment: Mr. Pierre Nathie of Med2Mark...
Pitt Street Research Issues Updated Report on Achiko AG’s Business Expansion Towards COVID-19 Testing
October 01, 2020 10:29 ET | Achiko AG
SYDNEY, Australia, Oct. 01, 2020 (GLOBE NEWSWIRE) -- Pitt Street Research, based in Sydney, Australia has issued an updated report on Achiko AG (SWX: ACHI) (ACHI.SW) (ISIN: CH0522213468) (the...
Achiko Logo cropped.jpg
Achiko AG Announces Financial Results for Six Months Ended June 30, 2020
September 28, 2020 10:10 ET | Achiko AG
The outbreak of the Covid-19 pandemic towards the end of first quarter 2020 limited Achiko’s ability to execute on its business strategyAchiko responded by developing a Covid-19 testing and ecosystem...